 AMAG Pharmaceuticals NASDAQ:AMAG was upgraded by analysts at BidaskClub from a sell rating to a hold rating in a note issued to investors on Tuesday, BidAskClub reports. Several other brokerages have also recently weighed in on AMAG. Barclays reissued a buy rating and set a 11.00 price objective on shares of AMAG Pharmaceuticals in a ... 